Hepatitis C Threatens Mothers: Rohtak Study Reveals Alarming Miscarriage Rate
A concerning study by PGIMS, Rohtak, has unveiled a stark reality: 26% of pregnant women with Hepatitis C experienced miscarriages. This alarming statistic highlights the significant health risks associated with the viral infection during pregnancy.
The study, conducted at the prestigious medical institute, also revealed a 13% familial prevalence of Hepatitis B. This underscores the need for widespread awareness and preventative measures within families.
PGIMS has a significant track record in combating these viral diseases, having treated over 26,000 Hepatitis C and 12,000 Hepatitis B patients. Their efforts have resulted in the near-elimination of vertical transmission of Hepatitis B.
Furthermore, the institute’s proactive approach extended to vaccinating over 8,000 healthcare workers against Hepatitis B, showcasing a commitment to public health.
These findings, published on July 28, 2025, serve as a wake-up call for strengthening maternal healthcare and implementing robust Hepatitis screening and vaccination programs nationwide. The high miscarriage rate necessitates immediate attention to improve antenatal care and reduce the impact of Hepatitis C on expectant mothers and their families.